Congressional Letters & Responses
- RWC-340B Principles and Comments on ASAP 340B Principles (January 22, 2024)
- Senate Finance Letter Re: Opposition to 340B Covered Entity Reporting Requirement Language (December 15, 2023)
- PrEP Bill Press Statement RWC-340B: (June 14, 2022)
- Response to Request for Input Regarding the 340B Program: Submitted to House Energy and Commerce Committee Ranking Member Greg Walden (R-OR) and Senate Health, Education, Labor and Pensions (HELP) Chairman Lamar Alexander’s (R-TN) (October 30, 2020)
- Bipartisan Congressional Sign on Letter: Regarding Recent Manufacturer Actions in the 340B Program (September 14, 2020)
- Press Statement: Ryan White Clinics Call on Congress, HHS, & HRSA to Stop Drug Manufacturers from Undermining Our Use of the 340B Program to Care for People with HIV (August 27, 2020)
- Letter to House Appropriations Committee: President’s 2021 Budget Proposal (July 7, 2020)
- Response to Sen. Alexander (R-TN) White Paper: “Preparing for the Next Pandemic” (June 26, 2020)
- Thank You Letter to: House Energy and Commerce Committee (October 28, 2019)
- Letter to Senator Alexander: (March 1, 2019)
- Patient Organization Letter: to House and Senate Leadership (May 14, 2018)
- HELP Act: Threatens Continuum of Care for HIV/AIDS Patients & Future of the 340B Program (April 16, 2018)
- PAUSE Act: Threatens Continuum of Care for HIV/AIDS Patients & Future of the 340B Program (April 16, 2018)
- Letter to Energy and Commerce Committee on 340B Report (February 13, 2018)
- Health Subcommittee Testimony for hearing on “Examining the 340B Drug Pricing Program” (March 24, 2015)